\n \n \n
\n
\n\n \n \n \n \n \n COVID-19 transmission, current treatment, and future therapeutic strategies.\n \n \n \n\n\n \n Salian, V. S; Wright, J. A; Vedell, P. T; Nair, S.; Li, C.; Kandimalla, M.; Tang, X.; Carmona Porquera, E. M; Kalari, K. R; and Kandimalla, K. K\n\n\n \n\n\n\n
Molecular pharmaceutics, 18(3): 754–771. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{salian2021covid,\n title={COVID-19 transmission, current treatment, and future therapeutic strategies},\n author={Salian, Vrishali S and Wright, Jessica A and Vedell, Peter T and Nair, Sanjana and Li, Chenxu and Kandimalla, Mahathi and Tang, Xiaojia and Carmona Porquera, Eva M and Kalari, Krishna R and Kandimalla, Karunya K},\n journal={Molecular pharmaceutics},\n volume={18},\n number={3},\n pages={754--771},\n year={2021},\n publisher={American Chemical Society}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Abstract PD7-04: Association between patient derived xenograft (PDX) take rate and breast cancer recurrence in the prospective breast cancer genome guided therapy study (BEAUTY).\n \n \n \n\n\n \n Boughey, J. C; Suman, V. J; Yu, J.; Santo, K.; Sinnwell, J. P; Carter, J. M; Kalari, K. R; Tang, X.; McLaughlin, S. A; Aspitia, A. M.; and others\n\n\n \n\n\n\n
Cancer Research, 81(4_Supplement): PD7–04. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{boughey2021abstract,\n title={Abstract PD7-04: Association between patient derived xenograft (PDX) take rate and breast cancer recurrence in the prospective breast cancer genome guided therapy study (BEAUTY)},\n author={Boughey, Judy C and Suman, Vera J and Yu, Jia and Santo, Katelyn and Sinnwell, Jason P and Carter, Jodi M and Kalari, Krishna R and Tang, Xiaojia and McLaughlin, Sarah A and Aspitia, Alvaro Moreno and others},\n journal={Cancer Research},\n volume={81},\n number={4\\_Supplement},\n pages={PD7--04},\n year={2021},\n publisher={The American Association for Cancer Research}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Abstract PS5-24: Novel genomic variants and pathways associated with baseline serum thymidine kinase 1 levels in HR-positive HER2-negative MBC patients commencing palbociclib and letrozole.\n \n \n \n\n\n \n Sullivan, C. C.; Kalari, K. R; Suman, V. J; Vedell, P. T; Moyer, A.; Casey, A. D E.; Sinnwell, J.; Tang, X.; Thompson, K.; Moreno-Aspitia, A.; and others\n\n\n \n\n\n\n
Cancer Research, 81(4_Supplement): PS5–24. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{sullivan2021abstract,\n title={Abstract PS5-24: Novel genomic variants and pathways associated with baseline serum thymidine kinase 1 levels in HR-positive HER2-negative MBC patients commencing palbociclib and letrozole},\n author={Sullivan, Ciara CO and Kalari, Krishna R and Suman, Vera J and Vedell, Peter T and Moyer, Ann and Casey, Abraham D Eyman and Sinnwell, Jason and Tang, Xiaojia and Thompson, Kevin and Moreno-Aspitia, Alvaro and others},\n journal={Cancer Research},\n volume={81},\n number={4\\_Supplement},\n pages={PS5--24},\n year={2021},\n publisher={The American Association for Cancer Research}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Clustering-based time series analysis on insulin response in the blood-brain barrier.\n \n \n \n\n\n \n Kalari, K. R; Wang, Z.; Tang, X.; Swaminathan, S. K; and Kandimalla, K. K\n\n\n \n\n\n\n
bioRxiv,2021–03. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{kalari2021clustering,\n title={Clustering-based time series analysis on insulin response in the blood-brain barrier},\n author={Kalari, Krishna R and Wang, Zengtao and Tang, Xiaojia and Swaminathan, Suresh K and Kandimalla, Karunya K},\n journal={bioRxiv},\n pages={2021--03},\n year={2021},\n publisher={Cold Spring Harbor Laboratory}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Association between patient derived xenograft (PDX) take rate and breast cancer recurrence in the prospective breast cancer genome guided therapy study (BEAUTY).\n \n \n \n\n\n \n Boughey, J. C; Suman, V. J; Yu, J.; Santo, K.; Sinnwell, J. P; Carter, J. M; Kalari, K. R; Tang, X.; McLaughlin, S. A; Aspitia, A. M.; and others\n\n\n \n\n\n\n In
CANCER RESEARCH, volume 81, 2021. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA …\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@inproceedings{boughey2021association,\n title={Association between patient derived xenograft (PDX) take rate and breast cancer recurrence in the prospective breast cancer genome guided therapy study (BEAUTY)},\n author={Boughey, Judy C and Suman, Vera J and Yu, Jia and Santo, Katelyn and Sinnwell, Jason P and Carter, Jodi M and Kalari, Krishna R and Tang, Xiaojia and McLaughlin, Sarah A and Aspitia, Alvaro Moreno and others},\n booktitle={CANCER RESEARCH},\n volume={81},\n number={4},\n year={2021},\n organization={AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA~…}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Correction to: establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.\n \n \n \n\n\n \n Yu, J.; Qin, B.; Moyer, A. M; Sinnwell, J. P; Thompson, K. J; Copland III, J. A; Marlow, L. A; Miller, J. L; Yin, P.; Gao, B.; and others\n\n\n \n\n\n\n
Breast Cancer Research: BCR, 23. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{yu2021correction,\n title={Correction to: establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study},\n author={Yu, Jia and Qin, Bo and Moyer, Ann M and Sinnwell, Jason P and Thompson, Kevin J and Copland III, John A and Marlow, Laura A and Miller, James L and Yin, Ping and Gao, Bowen and others},\n journal={Breast Cancer Research: BCR},\n volume={23},\n year={2021},\n publisher={BMC}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Novel genomic variants and pathways associated with baseline serum thymidine kinase 1 levels in HR-positive HER2-negative MBC patients commencing palbociclib and letrozole.\n \n \n \n\n\n \n Sullivan, C. C.; Kalari, K. R; Suman, V. J; Vedell, P. T; Moyer, A.; Casey, A. D E.; Sinnwell, J.; Tang, X.; Thompson, K.; Moreno-Aspitia, A.; and others\n\n\n \n\n\n\n In
CANCER RESEARCH, volume 81, 2021. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA …\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@inproceedings{sullivan2021novel,\n title={Novel genomic variants and pathways associated with baseline serum thymidine kinase 1 levels in HR-positive HER2-negative MBC patients commencing palbociclib and letrozole},\n author={Sullivan, Ciara CO and Kalari, Krishna R and Suman, Vera J and Vedell, Peter T and Moyer, Ann and Casey, Abraham D Eyman and Sinnwell, Jason and Tang, Xiaojia and Thompson, Kevin and Moreno-Aspitia, Alvaro and others},\n booktitle={CANCER RESEARCH},\n volume={81},\n number={4},\n year={2021},\n organization={AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA~…}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease.\n \n \n \n\n\n \n Crist, A. M; Hinkle, K. M; Wang, X.; Moloney, C. M; Matchett, B. J; Labuzan, S. A; Frankenhauser, I.; Azu, N. O; Liesinger, A. M; Lesser, E. R; and others\n\n\n \n\n\n\n
Nature communications, 12(1): 2311. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{crist2021transcriptomic,\n title={Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease},\n author={Crist, Angela M and Hinkle, Kelly M and Wang, Xue and Moloney, Christina M and Matchett, Billie J and Labuzan, Sydney A and Frankenhauser, Isabelle and Azu, Nkem O and Liesinger, Amanda M and Lesser, Elizabeth R and others},\n journal={Nature communications},\n volume={12},\n number={1},\n pages={2311},\n year={2021},\n publisher={Nature Publishing Group UK London}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study (vol 19, 130, 2017).\n \n \n \n\n\n \n Yu, J.; Qin, B.; Moyer, A. M; Sinnwell, J. P; Thompson, K. J; Copland III, J. A; Marlow, L. A; Miller, J. L; Yin, P.; Gao, B.; and others\n\n\n \n\n\n\n
BREAST CANCER RESEARCH, 23(1). 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{yu2021establishing,\n title={Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study (vol 19, 130, 2017)},\n author={Yu, Jia and Qin, Bo and Moyer, Ann M and Sinnwell, Jason P and Thompson, Kevin J and Copland III, John A and Marlow, Laura A and Miller, James L and Yin, Ping and Gao, Bowen and others},\n journal={BREAST CANCER RESEARCH},\n volume={23},\n number={1},\n year={2021},\n publisher={BMC CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n Patient-derived xenograft engraftment and breast cancer outcomes in a prospective neoadjuvant study (BEAUTY).\n \n \n \n\n\n \n Boughey, J. C; Suman, V. J; Yu, J.; Santo, K.; Sinnwell, J. P; Carter, J. M; Kalari, K. R; Tang, X.; McLaughlin, S. A; Moreno-Aspitia, A.; and others\n\n\n \n\n\n\n
Clinical Cancer Research, 27(17): 4696–4699. 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{boughey2021patient,\n title={Patient-derived xenograft engraftment and breast cancer outcomes in a prospective neoadjuvant study (BEAUTY)},\n author={Boughey, Judy C and Suman, Vera J and Yu, Jia and Santo, Katelyn and Sinnwell, Jason P and Carter, Jodi M and Kalari, Krishna R and Tang, Xiaojia and McLaughlin, Sarah A and Moreno-Aspitia, Alvaro and others},\n journal={Clinical Cancer Research},\n volume={27},\n number={17},\n pages={4696--4699},\n year={2021},\n publisher={American Association for Cancer Research}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n FOXA1 overexpression suppresses interferon signaling and immune response in cancer.\n \n \n \n\n\n \n He, Y.; Wang, L.; Wei, T.; Xiao, Y.; Sheng, H.; Su, H.; Hollern, D. P; Zhang, X.; Ma, J.; Wen, S.; and others\n\n\n \n\n\n\n
The Journal of clinical investigation, 131(14). 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{he2021foxa1,\n title={FOXA1 overexpression suppresses interferon signaling and immune response in cancer},\n author={He, Yundong and Wang, Liguo and Wei, Ting and Xiao, Yu-Tian and Sheng, Haoyue and Su, Hengchuan and Hollern, Daniel P and Zhang, Xiaoling and Ma, Jian and Wen, Simeng and others},\n journal={The Journal of clinical investigation},\n volume={131},\n number={14},\n year={2021},\n publisher={American Society for Clinical Investigation}\n}\n\n
\n
\n\n\n\n
\n\n\n
\n\n\n
\n\n\n
\n
\n\n \n \n \n \n \n CORRECTION Open Access.\n \n \n \n\n\n \n Yu, J.; Qin, B.; Moyer, A. M; Sinnwell, J. P; Thompson, K. J; III, J. A C.; Marlow, L. A; Miller, J. L; Yin, P.; Gao13, B.; and others\n\n\n \n\n\n\n . 2021.\n
\n\n
\n\n
\n\n
\n\n \n\n \n\n \n link\n \n \n\n bibtex\n \n\n \n\n \n\n \n \n \n \n \n \n \n\n \n \n \n\n\n\n
\n
@article{yu2021correction,\n title={CORRECTION Open Access},\n author={Yu, Jia and Qin, Bo and Moyer, Ann M and Sinnwell, Jason P and Thompson, Kevin J and III, John A Copland and Marlow, Laura A and Miller, James L and Yin, Ping and Gao13, Bowen and others},\n year={2021}\n}\n\n
\n
\n\n\n\n
\n\n\n\n\n\n